Skip to main content

ImmunityBio, Inc. (NASDAQ: IBRX) Investor Securities Class Action Lawsuit 03/26/2026

  • If you purchased a significant amount of shares of ImmunityBio, Inc. (NASDAQ: IBRX) between January 19, 2026 and March 24, 2026, and / or if you purchased any NASDAQ: IBRX shares prior to January 2026 and continue to hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: May 26, 2026. NASDAQ: IBRX investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

March 26, 2026 - An investor in shares of ImmunityBio, Inc. (NASDAQ: IBRX) filed a lawsuit in the U.S. District Court for the Central District of California over alleged violations of Federal Securities Laws by ImmunityBio, Inc. in connection with certain allegedly false and misleading statements made between January 19, 2026 and March 24, 2026.   San Diego, CA based ImmunityBio, Inc....



You must register (for free) or login to view the entire case.